Evidence map›Paper›PMID 39315362›Full record

ArticleFrontiers in medical technology2024

Structural brain preservation: a potential bridge to future medical technologies.

Andrew T McKenzie, Ariel Zeleznikow-Johnston, Jordan S Sparks, Oge Nnadi, John Smart, Keith Wiley, Michael A Cerullo, Aschwin de Wolf, Francesca Minerva, Ramón Risco and 3 more

Abstract read
In one paragraph

Article in Frontiers in medical technology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Andrew T McKenzieApex Neuroscience, Salem, OR, United States.
Ariel Zeleznikow-JohnstonSchool of Psychological Sciences, Monash University, Melbourne, VIC, Australia.
Jordan S SparksApex Neuroscience, Salem, OR, United States.
Oge NnadiBrain Preservation Foundation, Ashburn, VA, United States.
John SmartBrain Preservation Foundation, Ashburn, VA, United States.
Keith WileyBrain Preservation Foundation, Ashburn, VA, United States.
Michael A CerulloBrain Preservation Foundation, Ashburn, VA, United States.
Aschwin de WolfAdvanced Neural Biosciences, Portland, OR, United States.
Francesca MinervaDepartment of Philosophy, University of Milan, Milano, Italy.
Ramón RiscoEscuela Superior de Ingeniería, Universidad de Sevilla & National Accelerators Center, CNA-CSIC, Seville, Spain.
George M ChurchDepartment of Genetics, Harvard Medical School, Boston, MA, United States.
João Pedro de MagalhãesInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.
Emil F KendziorraEuropean Biostasis Foundation, Riehen, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When faced with the prospect of death, some people would prefer a form of long-term preservation that may allow them to be restored to healthy life in the future, if technology ever develops to the point that this is feasible and humane. Some believe that we may have the capacity to perform this type of experimental preservation today-although it has never been proven-using contemporary methods to preserve the structure of the brain. The idea is that the morphomolecular organization of the brain encodes the information required for psychological properties such as personality and long-term memories. If these structures in the brain can be maintained intact over time, this could theoretically provide a bridge to access restorative technologies in the future. To consider this hypothesis, we first describe possible metrics that can be used to assess structural brain preservation quality. We next explore several possible methods to preserve structural information in the brain, including the traditional cryonics method of cryopreservation, as well as aldehyde-stabilized cryopreservation and fluid preservation. We focus in-depth on fluid preservation, which relies on aldehyde fixation to induce chemical gel formation in a wide set of biomolecules and appears to be a cost-effective method. We describe two theoretical recovery technologies, alongside several of the ethical and legal complexities of brain preservation, all of which will require a prudent approach. We believe contemporary structural brain preservation methods have a non-negligible chance of allowing successful restoration in the future and that this deserves serious research efforts by the scientific community.

Indexed as

biostasisbrain perfusionbrain preservationconnectomicsfluid preservationmolecular nanotechnology

Identifiers

PMID39315362
PMCPMC11416988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.